Related Experiment Videos
Transformed rat arterial smooth muscle cells induce platelet aggregation
Atherosclerosis
|October 1, 1994
Summary
Transformed arterial smooth muscle cells (SMC) can directly aggregate platelets by releasing ADP, a key factor in atherosclerosis-related thrombosis. This finding highlights a novel mechanism contributing to thrombotic complications in arterial disease.
Area of Science:
- Cardiovascular Biology
- Cell Biology
- Thrombosis Research
Background:
- Atherogenesis involves arterial smooth muscle cell proliferation, potentially of a transformed nature.
- Platelets play a crucial role in atherosclerotic lesion progression and thrombotic complications.
Purpose of the Study:
- To investigate if transformed arterial smooth muscle cells (SMC) can specifically aggregate platelets.
- To elucidate the mechanism by which transformed SMC interact with platelets.
Main Methods:
- Utilized established rat transformed arterial SMC lines (V6 and V8) and their normal counterparts.
- Employed an in vitro homologous rat system using a coagulo-aggregometer with platelet-rich plasma.
- Assessed platelet aggregation and plasma clotting induced by SMC suspensions and supernatants.
Main Results:
- Transformed SMC induced dose-dependent, ADP-like platelet aggregation, significantly higher than normal SMC.
- Supernatants from transformed SMC also induced aggregation, suggesting release of soluble factors.
- Platelet aggregation was inhibited by apyrase and iodoacetate, confirming ADP involvement.
- All SMC, normal and transformed, induced plasma clotting via tissue factor activity, inhibited by hirudin and phospholipase A2.
Conclusions:
- Transformed arterial SMC directly aggregate platelets through ADP release.
- This mechanism may be pathologically relevant in thrombosis associated with atherosclerosis.
- Transformed SMC also exhibit tissue factor activity, contributing to thrombin generation.